Enjoy complimentary customisation on priority with our Enterprise License!
The lacrimal duct stent tube market size is forecast to increase by USD 5.8 million, at a CAGR of 2.82% between 2023 and 2028. The market for treatments related to nasolacrimal duct obstruction (NLDO) is influenced by several key factors. Firstly, there is a notable increase in research activities focused on understanding and treating NLDO, driving innovation in medical devices and procedures. Additionally, there is a growing awareness among the general population about NLDO, leading to earlier diagnosis and treatment seeking. Furthermore, substantial investments in healthcare infrastructure and technologies bolster the development and accessibility of effective treatments for NLDO. These factors collectively contribute to a promising market landscape, characterized by advancements in treatment options, improved patient outcomes, and a growing market potential driven by evolving healthcare needs and capabilities.
For More Highlights About this Report, Request Free Sample
The market for treatments related to nasolacrimal duct obstruction (NLDO) is influenced by several key factors. Firstly, there is a notable increase in research activities focused on understanding and treating NLDO, driving innovation in medical devices and procedures. Additionally, there is a growing awareness among the general population about NLDO, leading to earlier diagnosis and treatment seeking. Furthermore, substantial investments in healthcare infrastructure and technologies bolster the development and accessibility of effective treatments for NLDO. These factors collectively contribute to a promising market landscape, characterized by advancements in treatment options, improved patient outcomes, and a growing market potential driven by evolving healthcare needs and capabilities.
Increasing research activities for NLDO is notably driving market growth. Tear duct obstruction, specifically in the nasolacrimal duct, can result in tears backing up and discharging from the eye instead of draining naturally through the nose. This condition, common among newborns, is often caused by the presence of the valve of Hasner, a membrane at the end of the tear duct, which affects approximately half of newborns but typically disappears soon after birth.
Moreover, other contributing factors for blocked tear ducts in children include absent puncta, a narrow tear duct system, infections, and incomplete development of the tear duct, which fails to connect with the nasal cavity. A common surgical intervention for this issue is the conjunctivo dacryocystorhinostomy (DCR) procedure, which involves creating a new tear drainage pathway between the tear sac and the nose, such as through the placement of a Jones tube. Thus, such factors are driving the growth of the market during the forecast period
Development of new surgical techniques is the key trend in the market. When the upper and lower canaliculi become obstructed, the normal flow of tears from the eyes to the nasal cavity is disrupted, leading to epiphora or watery eyes. The cause of canalicular obstruction is often unidentified, but it is believed to be related to aging, trauma, tumors, and certain medications. Traditional treatments include inserting a silicone tube into the canaliculus to enlarge it or performing surgery with an external incision, resulting in a scar of approximately 2 cm on the side of the nose.
Further, to address the limitations of these conventional methods, a team of otolaryngologists and ophthalmologists from Toho University Sakura Medical Center in Japan introduced a novel procedure called conjunctivoductivo-dacryocystorhinostomy. This advanced technique involves creating a new tear drainage pathway from the conjunctiva to the nasal cavity, eliminating the need for external incisions and tubes. Thus, such trends will shape the growth of the market during the forecast period.
Lack of skilled expertise in healthcare sector is the major challenge that affects the growth of the market. The market is witnessing significant growth due to the increasing number of conjunctivo-dacryocysto rhinostomy (CDR) procedures and Jones tube placements. The shortage of skilled healthcare professionals, including surgeons and medical technicians, in both developed and emerging economies is driving the demand for these minimally invasive procedures. The aging population of experienced healthcare professionals is retiring, leading to a scarcity of surgeons in surgical specialties.
As a result, there is a growing emphasis on training and upskilling existing medical personnel to perform these procedures. The market is poised to expand as medical institutions seek cost-effective solutions to address the shortage of specialized surgeons. The market is expected to grow steadily as more medical professionals are trained to perform these procedures, ensuring patient safety and improving overall healthcare outcomes. Hence, the above factors will impede the growth of the market during the forecast period
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Aurolab - The company offers lacrimal duct stent that are flexible stainless steel probes attached through a hollow medical graded silicone tube that can be used in conventional DCR procedure, under the brand name of Aurolab.
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The bicanalicular segment is estimated to witness significant growth during the forecast period. The Lacrimal Duct Stent Tube Market caters to the demand for medical devices used in addressing nasolacrimal duct obstruction, a common eye disorder affecting individuals of all ages, including newborns with syndromes such as Branchiooculofacial, CHARGE, and Goldenhar. Hospitals and ophthalmic clinics are primary consumers of these devices, utilized during surgical procedures and outpatient consultations. Viral transmission and environmental allergens can contribute to lacrimal system problems, necessitating less invasive operations like lacrimal intubation using silicone or polyethylene tubing, or biodegradable materials.
Get a glance at the market share of various regions Download the PDF Sample
The bicanalicular segment was the largest and was valued at USD 27.00 million in 2018. The medical device sector continues to innovate, with materials science advancing biocompatible stents that ensure high patency rates and reduce the risk of chronic dacryocystitis. Endoscopic dacryocystorhinostomy operations, performed in ambulatory surgery centers, employ advanced ophthalmology technology, including columnar lining and orbicularis oculi and Horner's muscle manipulation. Healthcare professionals prioritize respiratory support devices and personal protective equipment to minimize infection risks during procedures. As the aging global population increases, so does the need for effective lacrimal drainage apparatus. Rising awareness among healthcare professionals and advancements in ophthalmic technology contribute to market growth. Additionally, the development of silicone, polyethylene, and biodegradable materials continues to improve the functionality and safety of lacrimal intubation stents.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The market caters to hospitals and ophthalmic clinics, providing solutions for nasolacrimal duct obstruction, a common eye disorder. This condition can affect newborns and individuals with syndromes such as Branchiooculofacial, CHARGE, and Goldenhar. Surgical procedures like lacrimal intubation and endoscopic dacryocystorhinostomy are performed to address these issues. In the medical device sector, silicone tubing and lacrimal drainage apparatuses are popular choices due to their biocompatibility and less invasive nature. Material technology advancements have led to the use of biodegradable materials and columnar lining for improved patency rates.
In addition, the aging global population and increasing healthcare professional awareness have fueled market growth. Chronic dacryocystitis, environmental allergens, and viral transmission are key factors driving demand for biocompatible stents. The market also caters to ambulatory surgery centers and outpatient consultations. In the realm of ophthalmology technology, respiratory support devices, personal protective equipment, and orbicularis oculi and Horner's muscle understanding are essential for effective lacrimal system problem management. Materials science continues to play a crucial role in enhancing stent functionality and durability. Retinal diseases and health professionals' expertise further expand the market's scope. Overall, the Lacrimal Duct Stent Tube Market is poised for significant growth, catering to diverse needs in the healthcare sector.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million " for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
You may also interested in below market reports:
The market encompasses a diverse range of products and conditions. It includes options like Monocanalicular and Bicanalicular Lacrimal Duct Stent Tubes tailored for congenital nasolacrimal duct obstruction and syndromes such as Branchiooculofacial, CHARGE, and Goldenhar. These tubes address various eye disorders and challenges like post-traumatic tear drainage problems through Crawford and Nunchaku style lacrimal stents. They are crucial in minimally invasive ophthalmic operations, particularly in procedures like conjunctivodacryocystorhinostomy and Jones tube placement. Malleable stainless steel probes enhance flexibility in surgical approaches, ensuring precise placement in the lacrimal sac for optimal patient outcomes. The market's growth is driven by increasing research activities and healthcare investments, supported by growing awareness among patients and healthcare providers about effective treatment options.
In addition, the market offers specialized solutions such as Monocanalicular Lacrimal Duct Stent Tube and Bicanalicular Lacrimal Duct Stent Tube, crucial for treating conditions like Branchiooculofacial syndrome, CHARGE syndrome, and Goldenhar syndrome. These tubes are designed to address specific challenges, including post traumatic tear drainage problems, through innovative designs like Crawford style lacrimal stents. They play a pivotal role in procedures such as conjunctivo dacryocysto rhinostomy, ensuring effective tear drainage and patient comfort. The market for Lacrimal Duct Stent Tubes is driven by advancements in medical technology, increasing demand for minimally invasive treatments, and the growing prevalence of conditions requiring specialized ophthalmic interventions.
Market Scope |
|
Report Coverage |
Details |
Page number |
124 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 2.82% |
Market growth 2024-2028 |
USD 5.8 million |
Market structure |
Concentrated |
YoY growth 2023-2024(%) |
2.57 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 36% |
Key countries |
US, UK, China, Germany, and France |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Aurolab, Becton Dickinson and Co., Bess Medizintechnik GmbH, BVI Holdings Ltd., FCI Ophthalmics, Gunther Weiss Scientific Glassblowing Co. Inc., Kaneka Medical America LLC, Medline Industries LP, Surtex Instruments Ltd., and Walsh Medical Devices Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for market forecast period |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.